Skip to content
1st Biotherapeutics

1st Biotherapeutics

1st-102 (FB-101)  is a small molecule that functions as a c-Abl kinase inhibitor. c-Abl is a kinase implicated in neurodegenerative processes such as Parkinson's disease. By inhibiting c-Abl kinase, 1st-102 aims to reduce neuronal damage and slow disease progression.

Cart 0

Your cart is currently empty.

Start Shopping